BIODRUGS
SCI一区
EI同步收录
月刊
高认可度
更新时间: 浏览量:
期刊基础介绍
An essential resource for R&D professionals and clinicians with an interest in biologic therapies.
BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.
BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.
BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
期刊核心参数
通讯方式
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311
涉及的研究方向
医学-免疫学
出版国家或地区
NEW ZEALAND
出版语言
English
年文章数
55
PubMed Central (PMC)链接
平均录用比例
较易
CITESCORE
| CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.60 | 2.290 | 1.621 |
|
WOS期刊JCR分区
WOS分区等级:1区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:IMMUNOLOGY | SCIE | Q1 | 25/183 |
|
| 学科:ONCOLOGY | SCIE | Q1 | 46/326 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q1 | 24/352 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:IMMUNOLOGY | SCIE | Q1 | 35/183 |
|
| 学科:ONCOLOGY | SCIE | Q1 | 65/326 |
|
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q1 | 62/353 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 医学 2区 |
| 否 | 否 |
中科院2023年12月旧的升级版
| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 医学 2区 |
| 否 | 否 |